Thyroid Disease Information
"Adobe" and "the Adobe logo" are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
WARNING: Thyroid hormones, including Levoxyl®, either alone or together with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In patients with a normal functioning thyroid gland, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may provide serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic based weight loss drugs.
Levoxyl® is indicated for thyroid hormone replacement or supplemental therapy for hypothyroidism. Levoxyl® is contraindicated in patients with untreated thyrotoxicosis, acute myocardial infarction, uncorrected adrenal insufficiency, or hypersensitivity to any of its inactive ingredients. Levoxyl® is protected by U.S. Patent Number 6,555,581
Adverse reactions are primarily those of hyperthyroidism due to therapeutic overdose. Use with caution in patients with cardiovascular disease.
For a full list of adverse reactions, please see full prescribing information.
©2001-2008 King Pharmaceuticals,® Inc., 501 Fifth Street, Bristol, TN 37620. All rights reserved.
Levoxyl® is a registered trademark of King Pharmaceuticals Research and Development, Inc.
Accudose is a registered trademark of Monarch Pharmaceuticals,® Inc.
Monarch Pharmaceuticals® and King Pharmaceuticals Research and Development
are wholly owned subsidiaries of King Pharmaceuticals,® Inc.
Contact us at 1-866-LEVOXYL (538-6995).